On 14 December 2018, a joint briefing session between the Drug Office and HKAPI was held at the Public Health Laboratory Centre in Kowloon. It was overwhelmingly attended by about 90 members, with the majority being Regulatory Affairs staff. Following an introductory remark given by Mr. Frank Chan (Assistant Director (Drug), Department of Health), three Senior Pharmacists – Mr. Michael Yim, Mr. Henry Lau and Mr. Vincent Chiang, took turn to brief the audience on the Drug Office’s latest initiatives, changes in practices as well as future development regarding NCE, CORP and Clinical Trial Certificate applications. The speakers then opened the floor for questions and addressed each of them accordingly. The session was closed by Chief Pharmacist, Mr. Edwin Lam with a note of thanks and appreciation. |